[HTML][HTML] Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders
N De Bortoli, S Tolone, M Frazzoni… - Annals of …, 2018 - ncbi.nlm.nih.gov
Several studies have indicated an overlap between gastroesophageal reflux disease
(GERD) and various functional gastrointestinal disorders (FGIDs). The overlapping …
(GERD) and various functional gastrointestinal disorders (FGIDs). The overlapping …
Untangling nonerosive reflux disease from functional heartburn
Heartburn is a common symptom in clinical practice, but as many as 70% of patients have
normal findings from upper endoscopy. Most of these patients have nonerosive reflux …
normal findings from upper endoscopy. Most of these patients have nonerosive reflux …
Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial
NJ Shaheen, H Denison, K Björck, M Karlsson… - Gut, 2013 - gut.bmj.com
Objective Lesogaberan (AZD3355) is a novel γ-aminobutyric acid B-type receptor agonist
designed to treat gastro-oesophageal reflux disease (GERD) by inhibiting transient lower …
designed to treat gastro-oesophageal reflux disease (GERD) by inhibiting transient lower …
EsReflux protocol: Epidemiological study of heartburn and reflux-like symptoms in Spanish community pharmacies
E López-Pintor, M Puig-Moltó, B Lumbreras - International Journal of …, 2022 - mdpi.com
(1) Background: Heartburn and reflux discomfort are frequent reasons for consultation at the
community pharmacy. To facilitate the assistance work of the community pharmacist and its …
community pharmacy. To facilitate the assistance work of the community pharmacist and its …
To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non‐erosive gastroesophageal reflux disease in a …
D Ang, EK Teo, TL Ang, J Ong, CH Poh… - Journal of digestive …, 2010 - Wiley Online Library
OBJECTIVE: Non‐erosive reflux disease (NERD) constitutes the majority of patients with
gastroesophageal reflux disease (GERD). Esophageal pH monitoring is useful in …
gastroesophageal reflux disease (GERD). Esophageal pH monitoring is useful in …
Oesophageal afferent pathway sensitivity in non‐erosive reflux disease
Patients with non‐erosive reflux disease (NERD) report symptoms which commonly fail to
improve on conventional antireflux therapies. Oesophageal visceral hyperalgaesia may …
improve on conventional antireflux therapies. Oesophageal visceral hyperalgaesia may …
Adding acotiamide to gastric acid inhibitors is effective for treating refractory symptoms in patients with non-erosive reflux disease
H Yamashita, A Okada, K Naora, M Hongoh… - Digestive Diseases and …, 2019 - Springer
Background Approximately 30% of patients who are treated with proton pump inhibitors
(PPIs) for gastroesophageal reflux disease (GERD) experience persistent symptoms. No …
(PPIs) for gastroesophageal reflux disease (GERD) experience persistent symptoms. No …
[HTML][HTML] Distinction between patients with non-erosive reflux disease and functional heartburn
M Giacchino, V Savarino, E Savarino - Annals of gastroenterology …, 2013 - ncbi.nlm.nih.gov
Non-erosive reflux disease (NERD) and functional heartburn (FH) are two different clinical
entities and the clear distinction between the two forms is actually possible thanks to the use …
entities and the clear distinction between the two forms is actually possible thanks to the use …
[HTML][HTML] Трудности дифференциальной диагностики туберкулеза кишечника и болезни Крона. Клиническое наблюдение
ОВ Князев, АВ Каграманова, НА Фадеева… - Consilium …, 2022 - cyberleninka.ru
Представлен клинический случай туберкулеза кишечника у пациентки молодого
возраста, протекающего под маской болезни Крона. В статье отражены особенности …
возраста, протекающего под маской болезни Крона. В статье отражены особенности …
Randomized clinical trial: effect of the 5‐HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment
J Tack, F Zerbib, K Blondeau… - …, 2015 - Wiley Online Library
Abstract Background Approximately, 20–30% of patients with gastro‐esophageal reflux
disease (GERD) experience persistent symptoms despite treatment with proton pump …
disease (GERD) experience persistent symptoms despite treatment with proton pump …